Chemoinformaics analysis of 1-hexylcyclohexa-1,3-diene
| Molecular Weight | 164.292 | nRot | 5 |
| Heavy Atom Molecular Weight | 144.132 | nRig | 6 |
| Exact Molecular Weight | 164.156 | nRing | 1 |
| Solubility: LogS | -4.265 | nHRing | 0 |
| Solubility: LogP | 4.525 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 33.3759 |
| nHD | 0 | BPOL | 20.0641 |
| QED | 0.533 |
| Synth | 2.545 |
| Natural Product Likeliness | 1.634 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.745 |
| Pgp-sub | 0.046 |
| HIA | 0.003 |
| CACO-2 | -4.596 |
| MDCK | 0.0000139 |
| BBB | 0.552 |
| PPB | 0.9636 |
| VDSS | 3.5 |
| FU | 0.0319 |
| CYP1A2-inh | 0.813 |
| CYP1A2-sub | 0.826 |
| CYP2c19-inh | 0.413 |
| CYP2c19-sub | 0.871 |
| CYP2c9-inh | 0.244 |
| CYP2c9-sub | 0.856 |
| CYP2d6-inh | 0.58 |
| CYP2d6-sub | 0.874 |
| CYP3a4-inh | 0.116 |
| CYP3a4-sub | 0.277 |
| CL | 0.808 |
| T12 | 0.516 |
| hERG | 0.196 |
| Ames | 0.018 |
| ROA | 0.061 |
| SkinSen | 0.965 |
| Carcinogencity | 0.691 |
| EI | 0.978 |
| Respiratory | 0.964 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.723833 |